Bank of America’s Genelux GNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$784K Sell
323,865
-12,156
-4% -$33.1K ﹤0.01% 4641
2025
Q4
$1.47M Buy
336,021
+12,527
+4% +$67.7K ﹤0.01% 4289
2025
Q3
$1.36M Sell
323,494
-85,198
-21% -$303K ﹤0.01% 5124
2025
Q2
$1.17M Buy
408,692
+61
+0% +$161 ﹤0.01% 5189
2025
Q1
$1.1M Buy
408,631
+191,525
+88% +$719K ﹤0.01% 5150
2024
Q4
$512K Buy
217,106
+325
+0.1% +$865 ﹤0.01% 5518
2024
Q3
$514K Sell
216,781
-68,648
-24% -$151K ﹤0.01% 5468
2024
Q2
$557K Buy
285,429
+237,624
+497% +$808K ﹤0.01% 5275
2024
Q1
$307K Buy
47,805
+24,218
+103% +$220K ﹤0.01% 5642
2023
Q4
$330K Buy
23,587
+276
+1% +$4.36K ﹤0.01% 5776
2023
Q3
$571K Buy
23,311
+20,111
+628% +$510K ﹤0.01% 5230
2023
Q2
$105K Buy
+3,200
New +$90K ﹤0.01% 6183

Other funds holding GNLX

Bank of America's GNLX Position: Q1 2026 in Review

Bank of America reduced its Genelux (GNLX) stake by 3.6% in Q1 2026, selling an estimated $33.1K and leaving 323,865 shares worth $784K. The position accounts for ﹤0.01% of the portfolio, ranked #4641.

Bank of America first reported a position in GNLX in Q2 2023 and has held it in 12 quarters since. The position peaked at $1.47M in Q4 2025. 71 funds tracked by Wall St. Rank hold GNLX as of Q1 2026.

  • Bank of America held 323,865 shares of Genelux worth $784K as of Q1 2026.
  • Bank of America sold 12,156 Genelux shares in Q1 2026, an estimated $33.1K.
  • Genelux made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #4641 holding.
  • Bank of America first reported a position in Genelux in Q2 2023 and has held it in 12 quarters since.
  • Bank of America's Genelux position peaked at $1.47M in Q4 2025.
  • 71 funds tracked by Wall St. Rank held Genelux as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.